Source: Aurora Spine Corporation.
  • Aurora Spine Corporation (ASG) has announced a C$6.5 million private placement with institutional investors
  • 11,220,930 units will be issued at a price of $0.58 per common share and associated common warrant
  • It expects the closing date to occur on or about September 17, 2021
  • Aurora Spine Corporation brings new solutions to the spinal implant market through minimally invasive regenerative spinal implant technologies
  • Aurora Spine Corporation (ASG) closed down by 10.94 per cent trading at $0.57 per share

Aurora Spine Corporation (ASG) has announced a C$6.5 million private placement with institutional investors.

It will issue up to 11,220,930 units priced at $0.58 per common share and associated common warrant.

Each warrant entitles the holder to purchase one common share for $0.75 for up to three years after the closing of the offering.

Aurora expects the closing date to occur on or about September 17, 2021.

Aurora will offer shares and warrants in the United States on a private placement basis pursuant to exemptions from the registration requirements of the United States Securities Act of 1933.

No securities will be sold or offered for sale in Canada.

Aurora Spine Corporation brings new solutions to the spinal implant market through minimally invasive regenerative spinal implant technologies.

Aurora Spine Corporation (ASG) closed down by 10.94 per cent trading at $0.57.

More From The Market Online

Buzz on the Bullboards: Looking for volatility-proof stocks?

Investors saw developments in Canadian and U.S. stock markets, with attention on decisions made by central banks and moves in key sectors.
Scientific labratory

How a small-cap tech stock is broadening MRI technology 

Nanalysis Scientific (TSXV:NSCI) develops and makes compact MRI and nuclear magnetic resonance devices for clinical, lab and industrial use.

Canopy Growth fuels turnaround story with fresh capital

Canopy Growth (TSX:WEED) continues its turnaround story with a C$96.3 million exchange and subscription deal with an institutional investor.

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.